Right now, that's none other than Eli Lilly (NYSE: LLY). However, others are looking to challenge its dominance. Recent ...

CEO Albert Bourla sits down with Yahoo Finance Executive Editor Brian Sozzi to talk about when consumers can expect to see ...

Pfizer (PFE) managed to outbid competitor Novo Nordisk (NVO) to acquire Metsera (MTSR) in a deal valued at up to $10 billion.

Health and Human Services Secretary Robert F. Kennedy, Jr. has come under fire for his views on vaccines. In an interview ...

At a price of up to $10 billion, Pfizer has claimed victory in its bidding war against Novo Nordisk to acquire Metsera. It's ...

Shares of Metsera fell over 15% in premarket trading on Monday, after the weight-loss drug developer accepted a sweetened ...

Pfizer Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma ...

The executive who brought Novo Nordisk A/S’s first weight-loss shot to market is coming back as chairman of the Danish ...

Sunday Rose Reacts to Nicole Kidman’s Onstage 'Arrest' by Sabrina Carpenter Former TV anchor charged with first-degree murder ...

In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula ...

Technology is no longer a vertical; it’s the backbone of national security and economic strength,” Michael Kratsios, director ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...